SequelSEC

Adicet Bio, Inc. ACET

Pharmaceutical Preparations · CIK 0001720580 · Fiscal year ends 1226

AnnualQuarterlyTTM
Revenue
Unavailable
Fiscal year ended 2026-06-30
Operating income
-$22.30M
Fiscal year ended 2026-06-30
Free cash flow
-$20.02M
Fiscal year ended 2026-06-30

Adicet Bio, Inc. (ACET) reported net income of -$21.36M for the fiscal year ended 2026-06-30. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from Adicet Bio, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Pharmaceutical Preparations.

Income

Adicet Bio, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
RevenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Cost of revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Gross profitUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Operating income-$22.30MUnavailable-$31.89M-$27.95MUnavailableUnavailable-$30.74M-$33.15MUnavailableUnavailable
Net income-$21.36MUnavailable-$30.52M-$26.86MUnavailableUnavailable-$28.73M-$30.48MUnavailableUnavailable
Research & development$18.45MUnavailable$25.04M$22.85MUnavailableUnavailable$23.27M$26.25MUnavailableUnavailable
Weighted-average diluted sharesshares 10.75MUnavailableUnavailableshares 91.09MUnavailableUnavailableUnavailableshares 90.85MUnavailableUnavailable
Pretax income-$21.22MUnavailable-$30.52M-$26.86MUnavailableUnavailable-$28.73M-$30.48MUnavailableUnavailable
Income tax expense$143.00KUnavailable$0$0UnavailableUnavailable$0$0UnavailableUnavailable
Diluted EPS$-1.99UnavailableUnavailable$-0.29UnavailableUnavailableUnavailable$-0.34UnavailableUnavailable
Selling, general & administrativeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
General & administrative$3.85MUnavailable$6.85M$5.10MUnavailableUnavailable$7.47M$6.90MUnavailableUnavailable
Selling & marketingUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Balance

Adicet Bio, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Cash & equivalents$33.13MUnavailable$38.92M$29.10MUnavailableUnavailable$56.50M$105.48MUnavailableUnavailable
Total assets$148.17MUnavailable$192.36M$140.48MUnavailableUnavailable$220.22M$245.96MUnavailableUnavailable
Current assets$120.76MUnavailable$160.93M$106.49MUnavailableUnavailable$180.14M$206.32MUnavailableUnavailable
Total liabilities$28.03MUnavailable$33.14M$31.34MUnavailableUnavailable$33.61M$34.43MUnavailableUnavailable
Current liabilities$18.00MUnavailable$21.53M$18.94MUnavailableUnavailable$19.39M$19.39MUnavailableUnavailable
Total equity incl. NCI$120.14MUnavailable$159.21M$109.14MUnavailableUnavailable$186.61M$211.53MUnavailableUnavailable
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
InventoryUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts receivableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
GoodwillUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debtUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts payable$3.59MUnavailable$4.74M$4.29MUnavailableUnavailable$4.83M$2.50MUnavailableUnavailable

Cash flow

Adicet Bio, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Operating cash flow-$19.82MUnavailable-$20.91M-$22.31MUnavailableUnavailable-$24.10M-$22.01MUnavailableUnavailable
Capital expenditures$202.00KUnavailable-$10.00K$209.00KUnavailableUnavailable$176.00K$401.00KUnavailableUnavailable
Investing cash flow$16.65MUnavailable-$44.54M$16.84MUnavailableUnavailable-$22.12M-$96.58MUnavailableUnavailable
Financing cash flow$58.00KUnavailable$75.23M-$150.00KUnavailableUnavailable$137.00K$0UnavailableUnavailable
Net change in cash-$3.11MUnavailable$9.79M-$5.62MUnavailableUnavailable-$46.08M-$118.59MUnavailableUnavailable
Stock-based compensation$1.40MUnavailable$5.65M$2.50MUnavailableUnavailable$3.77M$6.80MUnavailableUnavailable
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Depreciation & amortization$1.20MUnavailable$1.47M$1.60MUnavailableUnavailable$1.62M$1.60MUnavailableUnavailable

Derived

Adicet Bio, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Free cash flow-$20.02MUnavailableUnavailable-$22.52MUnavailableUnavailable-$24.28M-$22.41MUnavailableUnavailable
Gross marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Operating marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
FCF marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
SBC / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Current ratio6.71xUnavailable7.47x5.62xUnavailableUnavailable9.29x10.64xUnavailableUnavailable
Revenue YoY growthUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Net marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
R&D / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
CapEx / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debt / equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rateUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open ACET in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-05View SEC filing
10-Q · Filed 2026-05-13View SEC filing
10-K · Filed 2026-03-12View SEC filing
10-Q · Filed 2025-11-05View SEC filing
10-Q · Filed 2025-08-07View SEC filing
10-Q · Filed 2025-05-06View SEC filing

Companies in the same industry

AAGH AARD ABBV ABCL ABEO ABT ABUS ABVC ACAD ACRS ACRV ACTU

Reconciliation checks needing review

14 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.

gross profit bridgeinconsistent2026-03-31

Withheld: cost revenue, revenue could not be reconciled with the rest of this filer’s statement.

balance equationinconsistent2026-03-31

Withheld: assets, equity, liabilities could not be reconciled with the rest of this filer’s statement.

balance equationinconsistent2025-06-30

Withheld: assets, equity, liabilities could not be reconciled with the rest of this filer’s statement.

gross profit bridgeinconsistent2025-06-30

Withheld: cost revenue, revenue could not be reconciled with the rest of this filer’s statement.

gross profit bridgeinconsistent2025-03-31

Withheld: cost revenue, revenue could not be reconciled with the rest of this filer’s statement.

balance equationinconsistent2025-03-31

Withheld: assets, equity, liabilities could not be reconciled with the rest of this filer’s statement.

balance equationinconsistent2024-06-30

Withheld: assets, equity, liabilities could not be reconciled with the rest of this filer’s statement.

gross profit bridgeinconsistent2024-06-30

Withheld: cost revenue, revenue could not be reconciled with the rest of this filer’s statement.

gross profit bridgeinconsistent2024-03-31

Withheld: cost revenue, revenue could not be reconciled with the rest of this filer’s statement.

balance equationinconsistent2024-03-31

Withheld: assets, equity, liabilities could not be reconciled with the rest of this filer’s statement.

gross profit bridgeinconsistent2023-06-30

Withheld: cost revenue, revenue could not be reconciled with the rest of this filer’s statement.

balance equationinconsistent2023-06-30

Withheld: assets, equity, liabilities could not be reconciled with the rest of this filer’s statement.